feed,title,long_url,short_url
SeekingAlpha,Kymera Therapeutics gets FDA clearance to start phase 1 trial of KT-413 for blood cancer,https://seekingalpha.com/news/3775323,
SeekingAlpha,Ethereum continues to outshine Bitcoin amid crypto market rally; Shiba Inu soars,https://seekingalpha.com/news/3775324,
SeekingAlpha,SPAC watch: Super Group attracts attention as potentially next big thing in U.S. sports betting,https://seekingalpha.com/news/3775327,
SeekingAlpha,"BeyondSpring, CTI BioPharma gain ahead of FDA decision for key drugs",https://seekingalpha.com/news/3775326,
SeekingAlpha,AcuityAds appoints new CFO,https://seekingalpha.com/news/3775325,
SeekingAlpha,"Safe-T Group EPS misses by $0.01, beats on revenue",https://seekingalpha.com/news/3775322,
